SUBSCRIBE
SUBSCRIBE
News   Business

Proteonomix, Inc. (PROT) Announces That It Is Negotiating a Relationship With South Korean Researchers and Entrepreneurs

October 28, 2008 | 
1 min read
MOUNTAINSIDE, NJ--(Marketwire - October 28, 2008) - Proteonomix, Inc. (PINKSHEETS: PROT) announces that it is negotiating with South Korean medical scientists and entrepreneurs to establish joint ventures in the following areas:
Alliances
MORE ON THIS TOPIC
Business people shaking hand in China.
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Concept art for large layoffs showing a line of blocks a cliff
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Cairo, Egypt, October 31 2024: Novartis CO building in Egypt, Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, manufactures the drugs
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
September 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
 · 
2 min read
 · 
Heather McKenzie